Galmed to acquire Colospan for $4.5 million in medical device deal
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announced it has entered into a definitive agreement to acquire Colospan Ltd., a medical device ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
